GSK and Bharat Biotech collaborate to reduce malaria vaccine price, enhance production, and supply to Gavi by 2028.

Bharat Biotech and GSK will lower the malaria vaccine price to under $5 by 2028. This is due to better processes and more ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world's first malaria ...

Bharat Biotech & GSK to slash malaria vaccine price by over 50% by 2028, aiming for increased access in Africa. A major step ...

Bharat Biotech International will start supplying world’s first malaria vaccine RTS.S, developed by global biopharma major GSK, to vaccine alliance Gavi from 2026.

Bharat Biotech International Limited (BBIL) and GSK plc, a Global Pharma Company, today announced their commitment to Gavi, the Vaccine Alliance (Gavi), in the continued roll out of the world’s first ...

Bharat Biotech International Ltd and GSK plc on Wednesday said they will reduce the price of the world’s first malaria vaccine for children ‘RTS,S’ developed by GSK, PATH and partners, by more than ...

Vaccine maker Bharat Biotech International Ltd and British biopharma giant GSK plc will be slashing the prices of the world’s ...

Drugmakers Bharat Biotech and GSK will cut the price of their malaria vaccine to below $5 per dose by 2028, more than halving ...

HYDERABAD: Bharat Biotech International Limited (BBIL) and GSK plc on Wednesday announced a price reduction on the world’s first malaria vaccine, RTS.S. The vac ...